Rosiglitazone and implications for pharmacovigilance.

Kazi, Dhruv. 2007. “Rosiglitazone and Implications for Pharmacovigilance.”. BMJ (Clinical Research Ed.) 334 (7606): 1233-4.
Publisher's Version

Abstract

Postsurveillance data should be systematically collected, timely, and publicly available

Last updated on 09/26/2024
PubMed